Physician profile
Jeffrey E Kauffman
NPI 1467440974
$1,205.65
in general payments reported to CMS, 2019-2025
7 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $137 · 2021: $43.65 · 2022: $61.92 · 2023: $144 · 2024: $282 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $570.28 | 2019-2025 | |
| Stryker Corporation | $238.50 | 2019-2024 | Citrefix, 7 X 23mm Citrelock Implant, Ortholoc 3di |
| Organogenesis INC. | $180.62 | 2019-2025 | Novachor, Nushield, Via Matrix |
| Smith+Nephew, INC. | $110.26 | 2022-2025 | Grafix Pl, Stravix Pl, Stravix |
| Tactile Systems Technology INC | $69.66 | 2023 | Flexitouch Plus, Entre Plus |
| Medtronic, INC. | $18.18 | 2023 | Hawkone |
| Osiris Therapeutics INC. | $18.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kauffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.